Glycyx

Glycyx

Pharmaceuticals, San Francisco, California, 90801, United States, 1-10 Employees

glycyxtherapeutics.com

  • LinkedIn

Who is GLYCYX

Glycyx is a biotech company transforming cancer patients quality of life and improving survival by reversing the negative impact that opioids have on the effectiveness of anti-PD1 cancer ...

Read More

map
  • San Francisco, California, 90801, United States Headquarters: San Francisco, California, 90801, United States
  • 2020 Date Founded: 2020
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

checked-icon Does something look wrong? Fix it. | View contact records from GLYCYX

Glycyx Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Glycyx

Answer: Glycyx's headquarters are located at San Francisco, California, 90801, United States

Answer: Glycyx's official website is https://glycyxtherapeutics.com

Answer: Glycyx's revenue is Under $1 Million

Answer: Glycyx has 1-10 employees

Answer: Glycyx is in Pharmaceuticals

Answer: Glycyx contact info: Phone number: Website: https://glycyxtherapeutics.com

Answer: Glycyx is a biotech company transforming cancer patients quality of life and improving survival by reversing the negative impact that opioids have on the effectiveness of anti-PD1 cancer treatments. Glycyx has a small molecule opioid antagonist with a planned indication for Opioid Induced Checkpoint Inhibitor failure in late stage solid tumors. Our lead drug enables a re-challenge of checkpoint inhibitor failures in last line patients. It has a direct effect inhibiting tumor growth and metastasis and shows a significant improvement in immune infiltration in solid tumors increasing the effectiveness of checkpoint inhibitors to infiltrate cancers by 50%. CMC is complete, prior Phase 2 with minimal safety. Preparing for a 3-arm Phase 2 study in head and neck, lung and hepatocellular cancer.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access